Related Experiment Video
Updated: Mar 24, 2026
Treating SCA1 Mice with Water-Soluble Compounds to Non-Specifically Boost Mitochondrial Function
Published on: January 22, 2017
Mitochondrial Targeted Antioxidant in Cerebral Ischemia
Ejaz Ahmed1, Tucker Donovan1, Lu Yujiao1
1Department of Neuroscience and Regenerative Medicine, Georgia Regents University, Augusta, GA 30912, USA.
Abstract:
There has been much evidence suggesting that reactive oxygen species (ROS) generated in mitochondria during cerebral ischemia play a major role in programming the senescence of organism. Antioxidants dealing with mitochondria slow down the appearance and progression of symptoms in cerebral ischemia and increase the life span of organisms. The mechanisms of mitochondrial targeted antioxidants, such as SKQ1, Coenzyme Q10, MitoQ, and Methylene blue, include increasing adenosine triphosphate (ATP) production, decreasing production of ROS and increasing antioxidant defenses, providing benefits in neuroprotection following cerebral ischemia. A number of studies have shown the neuroprotective role of these mitochondrial targeted antioxidants in cerebral ischemia. Here in this short review we have compiled the literature supporting consequences of mitochondrial dysfunction, and the protective role of mitochondrial targeted antioxidants.
Insights
Mitochondrial reactive oxygen species (ROS) drive aging after brain ischemia. Targeting these with antioxidants like MitoQ improves neuroprotection and extends lifespan by boosting ATP and antioxidant defenses.
Area of Science:
- Mitochondrial Biology
- Neuroscience
- Gerontology
Background:
- Mitochondria generate reactive oxygen species (ROS) during cerebral ischemia, contributing to organismal senescence.
- Mitochondrial dysfunction is a key factor in the progression of cerebral ischemia.
- Antioxidants targeting mitochondria show promise in mitigating ischemia-induced damage.
Purpose of the Study:
- To review the consequences of mitochondrial dysfunction in cerebral ischemia.
- To highlight the neuroprotective role of mitochondrial-targeted antioxidants.
- To explore the mechanisms by which these antioxidants confer benefits.
Main Methods:
- Literature review of studies on mitochondrial dysfunction and antioxidants in cerebral ischemia.
- Analysis of mechanisms including ATP production, ROS reduction, and enhanced antioxidant defenses.
- Compilation of evidence supporting neuroprotection by specific antioxidants (e.g., SKQ1, CoQ10, MitoQ, Methylene Blue).
Main Results:
- Mitochondrial ROS play a critical role in senescence following cerebral ischemia.
- Mitochondrial-targeted antioxidants effectively slow disease progression and increase lifespan.
- These antioxidants enhance neuroprotection through improved ATP synthesis and reduced oxidative stress.
Conclusions:
- Mitochondrial dysfunction is a significant contributor to cerebral ischemia pathology.
- Mitochondrial-targeted antioxidants offer a promising therapeutic strategy for neuroprotection.
- Further research into these antioxidants could lead to improved treatments for ischemia and aging.
